Skip to main content
Premium Trial:

Request an Annual Quote

Alexander Cappello and Sara Cunningham


Benitec said last week that it has appointed Alexander Cappello to its board of directors.

Cappello is chairman, CEO, and co-founder of the Cappello Capital, an investment banking firm and strategic advisor to Benitec.

Prior to founding Cappello Capital, Cappello founded the Cappello Group, a parent to the merchant and banking firms Swiss American Financial and Euro American Financial.

Cappello holds a BS from the Marshall School of Business at the University of Southern California.

Benitec also announced this week that Sara Cunningham has been confirmed as the CEO of the company after assuming the role of acting CEO following the resignation of John McKinley (see RNAi News, 1/21/2005).

Cunningham has also been appointed to the company’s board of directors.

Before founding Avocel, an RNAi firm acquired by Benitec, Cunningham held positions at BD Biosciences and Clontech.


The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.